IL6 and cancer: Reports have suggested that elevated levels of IL-6 are mechanistically linked to poor cancer prognosis via IL-6-induced activation of miR-21 via the activation of the STAT3 pathway [28]—miR-21 has been associated with poor survival in lung cancer in multiple studies [29, 30].